Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Uterine Prolapse 1Uterine Cervical Neoplasms 1Surgery 1Precancerous Conditions 1Ovarian Neoplasms 1Menstruation Disturbances 1Leiomyoma 1Invasive Breast Carcinoma 1Endometriosis 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Adenomyosis 1

Interventions

ruxolitinib 1fludarabine phosphate 1Whole-Body Irradiation 1Tacrolimus 1Sirolimus 1Robotic Surgical Procedures 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Hysterectomy 1Etoposide 1Cyclosporine 1Cyclophosphamide 1CPI-0610 1Busulfan 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × Robotic Surgical Procedures × 30 days × Clear all
NCT07120945 2026-06-02

Embrace Gyn

Medtronic - MITG

Phase NA Active not recruiting
70 enrolled
GynecologicOther neoplasm

Uterine Cervical Neoplasms, Endometriosis, Leiomyoma, Menstruation Disturbances, Ovarian Neoplasms, Precancerous Conditions, Uterine Prolapse, Endometrial Neoplasms, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡